Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Each compounded tirzepatide dosage contains the same active ingredient found in Mounjaro and Zepbound
TRIUMPH-4 (28.7% weight loss, knee OA population, December 2025), TRIUMPH-1 (28.3%, general obesity, May 2026), TRANSCEND-T2D-1 (-2.0% HbA1c, 16.8% weight loss, June 2026), TRIUMPH-2 (20.8% weight loss, obesity + diabetes, July 23, 2026), and TRIUMPH-3 (22.6% weight loss, obesity + cardiovascular disease, July 23, 2026) have all reported positive results
First-Line OTC: Simethicone Simethicone (Gas-X, Phazyme, and generics) acts as an antifoaming agent
What Happens During the Medication Transition The transition period typically involves a washout phase where you discontinue tirzepatide before starting semaglutide
Research suggests that weight gain significantly increases OSA risk, while weight reduction can lead to meaningful improvements in OSA severity
Retrieved from Gao, X., Hua, X., Wang, X., et al
